Cincinnati, OH7 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Cincinnati, OH

Find 7 actively recruiting chronic lymphocytic leukemia clinical trials in Cincinnati, OH. Connect with local research sites and explore new treatment options.

7
Active Trials
5
Sponsors
660
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Cincinnati

About Chronic Lymphocytic Leukemia Clinical Trials in Cincinnati

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 7 chronic lymphocytic leukemia clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 660 participants. Research is being sponsored by Nurix Therapeutics, Inc., Eli Lilly and Company, Lomond Therapeutics Holdings, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Cincinnati — FAQ

Are there chronic lymphocytic leukemia clinical trials in Cincinnati?

Yes, there are 7 chronic lymphocytic leukemia clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cincinnati?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.

Are clinical trials in Cincinnati free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 7 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated October 18, 2026 from ClinicalTrials.gov